Functional roles of evolutionary conserved motifs and residues in vertebrate chemokine receptors

Journal of Leukocyte Biology

Volumn 97, Issue 1, 2015, Pages 39-47

  Nomiyama, Hisayuki ^a   Yoshie, Osamu ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

CWxP motif; Dry motif; Micro switch DRY motif; NP Y motif; Receptor activation mechanism; T P motif

Indexed keywords

CHEMOKINE RECEPTOR; LIGAND;

ARTICLE; CELL MIGRATION; GENE ACTIVATION; GENETIC CONSERVATION; MOLECULAR PHYLOGENY; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN MOTIF; VERTEBRATE; AMINO ACID SEQUENCE; ANIMAL; CLASSIFICATION; EVOLUTION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN TERTIARY STRUCTURE;

VERTEBRATA;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL EVOLUTION; CONSERVED SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CHEMOKINE;

EID: 84925287061     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2RU0614-290R     Document Type: Article

References (65)

1. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
2. Zlotnik, A, Yoshie, O. (2012) The chemokine superfamily revisited. Immunity 36, 705-716.
3. Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., Mantovani, A., Matsushima, K., Murphy, P. M., Nibbs, R., Nomiyama, H., Power, C. A., Proudfoot, A. E., Rosenkilde, M. M., Rot, A., Sozzani, S., Thelen, M., Yoshie, O., Zlotnik, A. (2013) International Union of Basic and Clinical Pharmacology, [corrected], LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol, Rev. 66, 1-79.
4. Sallusto, F., Baggíolini, M. (2008) Chemokines and leukocyte traffic. Nat. Immunol. 9, 949-952.
5. Zlotnik, A., Burkhardt, A. M., Homey, B. (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol. 11, 597-606.
6. White, G. F. Iqbal, A. J., Greaves, D. R. (2013) CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol. Rev. 65, 47-89.
7. Nomiyama, H, Osada, N. Yoshie, O. (2013) Systematic classification of vertebrate chcmokincs based on conserved synteny and evolutionary history. Genes Cells 18, 1-16.
8. Bajoghli, B. (2013) Evolution and function of chemokine receptors in the immune system of lower vertebrates. Eur. J. Immunol. 43, 1686-1692.
9. Mantovani, A., Bonecchi, R, Locati, M. (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 6, 907-918.
10. Graham, G. J. (2009) D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur.J. Immunol. 39, 342-351.
11. Nibbs, R. J., Graham, G.J. (2013) Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13, 815-829.
12. Graham, G. J., Locati, M., Mantovani, A., Rot, A., Thelen, M. (2012) The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145, 30-38.
13. Nomiyama, H., Osada, N., Yoshie, O. (2011) A family tree of vertebrate chemokine receptors for a unified nomenclature. Dev. Comp. Immunol. 35, 705-715.
14. Jensen, A. S., Sparre-Ulrich, A. H., Davis-Poynter, N., Rosenkilde, M. M. (2012) Structural diversity in conserved regions like the DRY-motif among viral 7TM receptors- consequence of evolutionary pressure? Adv. Virol. 2012, 231813.
15. Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., Schwartz, T. W. (2009) Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol. Sci. 30, 249-259.
16. Rummel, P. C., Thiele, S., Hansen, L. S., Petersen, T. P. Sparre-Ulrich, A. H, Ulvcn, T., Rosenkilde, M. M. (2013) Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5. Mol. Pharmacol. 84, 335-345.
17. Peeters, M. G., van Westen, G. J., Li, O., IJzcrman, A. P. (2011) Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trench Pharmacol Sci. 32, 35-42.
18. Szpakowska, M. Fievez, V., Arumugan. K., van Nuland, N., Schmit, J. C., Chevigné, A. (2012) Function, diversity and therapeutic potential of the N-tcrminal domain of human chemokine receptors. Biochem. Pharmacol. 84, 1366-1380.
19. Wu, B., Chien, F. Y., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Ahagyan, R, Brooun, A., Wells, P., Bi, F. C., Hamel, D. J., Kuhn, P., Handel, T. M., Cherezov, V., Stevens, R. C. (2010) Stiuctures of the CXCR4 chemokine CPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071.
20. Zhou, H. Tai, H. H. (2000) Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding. Arch. Biochem. Biophys. 373, 211-217.
21. Scholtcn, D. J. Canals, M., Maussang, D., Roumen, L., Smit, M. J., Wijtmans, M., de Graaf, C., Vischer, H. F., Leurs, R. (2012) Pharmacological modulation ot chemokine receptor function. Br. J. Pharmacol. 165, 1617-1643.
22. Rajagopalan. L., Rajarathnam, K. (2006) Structural basis of chemokine receptor function-a model for binding affinity and ligand selectivity. Biosci. Rep. 26, 325-339.
23. Monteclaro, F. S., Charo, I. F. (1996) The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-lalpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol. Chem. 271, 19084-19092.
24. Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D., Mackay, C. R., Qin, S. (1996) Discrete steps in binding and signaling of interleukin-8 with its receptor. J. Biol. Chem. 271, 31202-31209.
25. Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C, De Leener, A., Vassart, G., Dorns, R. W., Proudfoot, A, Parmcntier, M. (2003) The core domain of chemokines binds GCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 278, 5179-5187.
26. Blanpain, C., Doranz, B. J. Vakili.J. Rucker,J., Govaerts, C., Baik, S. S., Lorthioir, O., Migeotte, I., Libert, F., Baleux, F., Vassart, G., Doms, R. W., Parmcntier, M. (1999) Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol. Chem 274, 34719-34727.
27. Ludeman.J. P., Stone, M. J. (2014) The structural role of receptor tyrosine sulfation in chemokine recognition. Br.J. Pharmacol. 171, 1167-1179.
28. Hewit, K. D., Fraser, A., Nibbs, R.J., Graham, G.J. (2014) The N-tcrminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.J Biol. Chem. 289, 12330-12342.
29. Kajumo, F., Thompson. D. A., Guo, Y., Dragic, T. (2000) Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 271, 240-247.
30. Zhou, N., Luo, Z., Luo. J., Liu, D., Hall, J. W., Pomerantz, R. J., Huang, Z. (2001) Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies. J Biol. Chem. 276, 42826-42833.
31. Huang, C. C., Lam, S. N., Acharya, P., Tang, M., Xiang, S. H., Hussan, S. S., Stanfield. R. L., Robinson, J., Sodroski, J. Wilson, I. A., Wyatt, R., Bewley, C. A., Kwong, P. D. (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gpl20 and CD4. Science 317, 1930-1934.
32. Schwartz, T. W-, Frimurer, T. M., Holst, B., Rosenkilde, M. M., Elling, B. E. (2006) Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 46, 481-519.
33. Ballesteros, J. A., Weinstein, H. (1995) Integrated methods for the construction of three-dimensional models and computational probing of structui e-function relations in G protein-coupled receptors. In Methods in Neurosciences, Receptor Molecular Biology (S. C. Scalfon, cd), Vol. 25, Elsevier, Philadelphia, 366-428.
34. Zhu, L., Zhao, Q, Wu, B. (2013) Structure-based studies of chemokine receptors. Curr. Opin. Struct. Biol. 23, 539-546.
35. Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L. Fenalti, G., Li, J., Zhang, W., Xie, X.,Yang, H., Jiang, H. Cherezov, V., Liu, H., Stevens, R. C., Zhao, Q., Wu, B. (2013) Structure of the CCR5 chemokine reccptor-HIV entry inhibitor maraviroc complex. Science 341 1387-1390.
36. Garcia-Perez, J., Rueda, P., Alcami, J., Rognan, D., Arenzana-Seisdedos, F., Lagane, B., Kellenberger, E. (2011) Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5) J. Biol Chem. 286, 33409-33421.
37. Govaerts, C., Blanpain, C., Deupi, X., Ballet, S., Ballesteros, J. A., Wodak S. J., Vassart, G., Pardo, L., Parmcntier, M. (2001) The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chcmokine-induced activation. J Biol. Chem. 276, 13217-13225.
38. Nomiyama, H., Osada, N., Yoshie, O. (2010) The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev. 21, 253-262.
39. Mortier, A., Gouwy, M., Van Damme, J., Proost, P. (2011) Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp. Cell Res. 317, 642-654.
40. Starr, A. E., Dufour, A., Maier, J., Overall, C. M. (2012) Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. J. Biol. Chem 287, 5848-5860.
41. Hofmann, K. P., Scheerer, P., Hildebrand, P. W., Choc, H. W., Park, J. H. Heck, M., Ernst, O. P. (2009) A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem. Sci. 34, 540-552.
42. Jenscn, P. C., Rosenkilde, M. M. (2009) Chapter 8. Activation mechanisms of chemokine receptors. Methods Enzymol. 461, 171-190
43. Valentin-Hansen, L., Holst, B., Frimurer, T. M., Schwartz, T. W. (2012) PheVl:09 (Phc6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation. J. Biol Chem. 287, 43516-43526.
44. Steen, A., Larsen, O., Thiele, S., Rosenkilde, M. M. (2014) Biased and G protein-independent signaling of chemokine receptors. Front. Immunol. 5, 277.
45. Baldwin, J. M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693-1703.
46. Schwartz, T. W. (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol 5, 434-444.
47. Rasmussen, S. G., Jensen, A. D., Liapakis, G., Ghanouni, P., Javitch, J. A., Gether, U. (1999) Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmcmbrane segment 6. Mol. Pharmacol. 56, 175-184.
48. Rasmussen, S. G., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., Mathiesen, J. M., Shah, S. T., Lyons, J. A., Cafřrey, M., Gellman, S. H., Steyaert, J., Skiniotis, G., Weis, W. I., Sunahara, Ŕ. K., Kobilka, B. K. (2011) Crystal structure of the ß2 adrenergic receptor-Gs protein complex. Nature 477, 549-555.
49. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., Cotecchia, S. (1996) Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578.
50. Morin, D., Cotte, N., Balestre, M. N., Mouillac, B., Manning, M., Breton, C., Barberis, C. (1998) The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett. 441, 470-475.
51. Alewijnse, A. E., Timmerman, H., Jacobs, E. H., Smit, M. J., Roovers, E., Cotecchia, S., Leurs, R. (2000) The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol. Pharmacol 57, 890-898.
52. Hoffmann, F., Müller, W., Schütz, D., Penfold, M. E., Wong, Y. H., Schulz, S., Stumm, R. (2012) Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues. J. Biol Chem. 287, 28362-28377.
53. Olivella, M., Caltabiano, G., Cordomí, A. (2013) The role of cysteine 6.47 in class A GPCRs. BMC Struct. Biol. 13, 3.
54. Mirzadegan, T., Benkö, G., Filipek, S., Palczewski, K. (2003) Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42, 2759-2767.
55. Steen, A., Thiele, S., Guo, D., Hansen, L. S., Frimurer, T. M., Rosenkilde, M. M. (2013) Biased and constitutive signaling in the CC-chcmokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7. J. Biol. Chem. 288, 12511-12521.
56. Pelé, J., Moreau, M., Abdi, H., Rodien, P., Castel, H., Chabbert, M. (2014) Comparative analysis of sequence covariation methods to mine evolutionary hubs: examples from selected GPCR families. Proteins 82, 2141-2156.
57. Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., Babu, M. M. (2013) Molecular signatures of G-protein-coupled receptors. Nature 494, 185-194.
58. Fritze, O., Filipek, S., Kuksa, V., Palczewski, K., Hofmann, K. P., Ernst, O.P. (2003) Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc. Natl. Acad. Sci. USA 100, 2290-2295.
59. Rosenkilde, M. M., Benned-Jensen, T., Frimurer, T. M., Schwartz, T. W. (2010) The minor binding pocket: a major player in 7TM receptor activation. Trends Pharmacol. Sci. 31, 567-574.
60. Rosenkilde, M. M., Schwartz, T. W. (2006) GluVII:06-a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors. Curr. Top. Med. Chem. 6, 1319-1333.
61. Jensen, P. C, Nygaard, R., Thiele, S., Elder, A., Zhu, Kolbeck, R., Ghosh, S., Schwartz, T. W., Rosenkilde, M. M. (2007) Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8. Mol Pharmacol. 72, 327-340.
62. Seibert, C., Ying, W., Gavrilov, S., Tsamis, F., Kuhmann, S. E., Palani, A., Tagat, J. R., Clader, J. W., McCombie, S. W., Baroudy, B. M., Smith, S.O., Dragic, T., Moore, J. P., Sakmar, T. P. (2006) Interaction of small molecule inhibitors of HIV-1 entry with CCR5. Virology 349, 41-54.
63. Chien, E. Y., Liu, W., Zhao, Q., Katritch, V., Han, G. W., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., Stevens, R. C. (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330, 1091-1095.
64. Mantovani, A. (1999) The chemokine system: redundancy for robust outputs. Immunol Today 20, 254-257.
65. Park, S. H., Das, B. B., Casagrande, F., Tian, Y., Nothnagel. H.J., Chu, M., Kiefer, H., Maier, K., De Angelis, A. A., Marassi, F. M., Opella, S. J. (2012) Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 491, 779-783.